Full Text View
Tabular View
No Study Results Posted
Related Studies
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
This study has been completed.
Study NCT00003569   Information provided by Roswell Park Cancer Institute

First Received on November 1, 1999.   Last Updated on January 30, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Lung Cancer
Neurotoxicity
Ovarian Cancer
Additional conditions recognized in this trial
Head and Neck Neoplasms
Lung Neoplasms
Neurotoxicity Syndromes
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Lung Diseases
Neoplasms
Neoplasms by Site
Nervous System Diseases
Ovarian Diseases
Poisoning
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Substance-Related Disorders
Thoracic Neoplasms
Urogenital Neoplasms
Interventions listed in this trial
cisplatin
dimesna
paclitaxel
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Roswell Park Cancer Institute
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services